查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1754098

生物材料市場報告（按類型（天然生物材料、金屬生物材料、陶瓷生物材料、聚合物生物材料）、應用（神經病學、心臟病學、骨科、傷口護理、牙科、整形外科等）和地區）2025 年至 2033 年

Biomaterials Market Report by Type (Natural Biomaterial, Metallic Biomaterial, Ceramic Biomaterial, Polymeric Biomaterial), Application (Neurology, Cardiology, Orthopedics, Wound Care, Dental, Plastic Surgery, and Others), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

2024年，全球生物材料市場規模達1,261億美元。展望未來， IMARC Group預計到2033年，市場規模將達到2,897億美元，2025-2033年期間的複合年成長率（CAGR）為9.7%。醫療保健產業的持續進步以及心血管疾病發生率的上升是推動市場發展的主要動力。

生物材料市場分析：

  • 主要市場促進因素：肌肉骨骼疾病患者數量的增加是刺激市場的主要促進因素之一。此外，可溶解縫合線和敷料、縫合釘以及用於傷口閉合的夾子等材料的應用日益增多，也是另一個重要的成長誘因。
  • 主要市場趨勢：聚合物合成、蛋白質和胜肽工程、分子自組裝和微製造技術的多項進步是推動市場發展的新興趨勢。
  • 地理趨勢：由於老年人口不斷成長且經常需要醫療干預，北美在整個市場佔據明顯主導地位。此外，研究機構數量的不斷增加和醫療保健基礎設施的健全也推動了該地區市場的成長。
  • 競爭格局：根據生物材料市場概況，一些知名公司包括 BASF SE、Berkeley Advanced Biomaterials、Carpenter Technology Corporation、Collagen Matrix Inc.、CoorsTek Inc.、Corbion NV、Dentsply Sirona、Evonik Industries AG、強生、Koninklijke DSM NV、Medker Hlclc、Stryx、Sttrem、Stry 和 Biomett. 等。
  • 挑戰與機會：嚴格的監管架構和繁瑣的臨床前測試阻礙了市場的發展。然而，隨著更具預測性的體內和體外模型在臨床使用前用於評估生物相容性，預計將在預測期內擴大市場。

生物材料市場趨勢：

3D列印技術的發展

包括3D列印技術在內的創新技術正在改善醫療植入物和醫療器材的設計和製造方式。此外，它們能夠生產出傳統方法難以或無法實現的患者專屬複雜形狀。因此，這些技術在牙科、骨科、義肢等解剖精準度至關重要的領域中得到了廣泛的應用。這反過來又為生物材料市場帶來了利潤豐厚的機會之一。例如，2024年2月，Nanavati Max超級專科醫院在孟買啟用了一個醫療3D列印實驗室，以支援高精度手術。這家開創性的機構與腫瘤科緊密結合，提供最先進的精密手術，這些手術需要在重建骨科、腫瘤科和專科牙科手術中精確、細緻地進行。此外，3D列印技術與生物材料廣泛融合，用於製造根據患者個體解剖結構量身定做的複雜醫療器材和植入物，在全球範圍內正日益受到廣泛關注。例如，2023年10月發表的一項研究成果，幫助卑爾根豪克蘭大學醫院的職業治療師利用3D列印和掃描技術開發個人化手部矯形器，從而減輕疼痛、最大程度地減少病情惡化、提高患者依從性等。此外，3D列印技術還能夠融合具有不同機械性能的梯度材料，這也對市場產生了積極影響。例如，2023年10月，贏創推出了許多醫療應用的植入級長絲和碳纖維增強聚醚醚酮（PEEK）。此外，這些技術還有助於治療慢性疾病，預計將在未來幾年推動生物材料市場的整體發展。例如，2023年7月，透過與韓國生命研究院、韓國機械研究院、科學技術資訊通訊部下屬機構的聯合研究，推出了全球首個增強自然殺手（NK）免疫細胞功能的3D生物列印技術。

組織工程的創新

組織工程在生物材料研究中扮演重要角色。它在開發用於維持、恢復或改善組織功能的生物替代品方面正日益受到廣泛關注。例如，2023年6月，OrganaBio宣布推出NeoPAC胎盤和臍帶組織，以加速再生醫學和細胞療法的進展。此外，透過提供僅供研究使用（RUO）和臨床級組織，OrganaBio鼓勵研究人員挖掘出生組織的潛力，從而開發創新療法以應對許多疾病。此外，對新型支架（一種經過精心設計，能夠引發理想的細胞相互作用，促進新組織形成的材料）的需求不斷成長，也推動了市場的發展。例如，2023年6月，組織工程領域的領先創新者之一3DBioFibR推出了兩款新型膠原纖維產品，即CollaFibR 3D和μCollaFibR支架。這些產品為組織培養和組織工程應用帶來了顯著的優勢。此外，各機構不斷增加對研發活動和研究設施的投資，以實現結構和功能更精準的組織工程，這也為生物材料市場收入做出了貢獻。例如，2023年1月，美國國家生物醫學影像與生物工程研究所 (NIBIB) 成立了生物醫學工程技術加速中心（BETA 中心），這是一個新的內部研究項目，旨在加速尖端技術的驗證、開發和傳播。該中心專注於生物感測、工程和合成生物學、生物醫學成像、奈米材料和生物材料等多個領域。

傷口敷料的應用日益廣泛

生物材料在先進傷口敷料中的應用日益廣泛，因為它們有助於改善多種傷口（包括急性和慢性損傷）的癒合過程和療效，這已成為重要的成長促進因素。此外，一些關鍵參與者正在開發用於傷口護理的永續材料。例如，2024年3月，科學技術部下屬高等科學技術研究所（IASST）的科學家團隊推出了由香蕉纖維製成的環保傷口敷料。此外，用於製造這種創新敷料的所有材料均來自當地，且均為天然材料，因此生產過程經濟高效、簡單無毒。此外，人們對基於生物材料的傷口敷料的日益青睞也推高了生物材料市場的價格。它們可以由各種材料製成，包括泡沫、水凝膠、薄膜等，這些材料通常富含抗菌劑等生物活性物質，以減少感染並促進組織再生。例如，2022年5月，瑞典醫療器材新創公司Amferia AB獲得了美國專利商標局（USPTO）授予的一項基礎專利，該專利涉及一種基於兩親性抗菌水凝膠的抗菌材料。同時，根據發表在《生物材料進展》雜誌上的研究成果，貝爾法斯特女王大學的一支研究團隊於2023年6月設計了一種3D列印繃帶（也稱為支架），為治療糖尿病足潰瘍（DFU）提供了一種創新方法。

全球生物材料市場細分：

按類型分列：

  • 天然生物材料
  • 金屬生物材料
  • 陶瓷生物材料
  • 聚合物生物材料

目前，金屬生物材料佔據最大的市場佔有率

此細分市場的成長得益於金屬生物材料優異的強度、最佳的耐用性和增強的生物相容性。因此，它們廣泛應用於承重應用，包括牙科植體、骨科植入物、心血管器械等。例如，2024年4月，波士頓微製造公司（BMF）宣布其創新型UltraThineer材料獲得美國食品藥物管理局（FDA）批准。此外，不銹鋼、鈦、鈷鉻合金等多種金屬因其優異的機械性能而被廣泛應用，這些性能可確保其在身體運動壓力下的長壽命和彈性。例如，2022年1月，根據《膠體與表面A》雜誌報導，研究人員利用奈米多孔TiO2有效改質TC26合金，以增強人工植入物的骨整合和生物活性。此外，2023年6月，莫斯科科技城經濟特區宣布開始生產鈦植入物。因此，不斷增加的產品應用將在未來幾年繼續推動金屬生物材料市場的需求。

按應用分類：

  • 神經病學
  • 心臟病學
  • 骨科
  • 傷口護理
  • 牙科
  • 整型手術
  • 其他

耐用的陶瓷、金屬和聚合物基材料對於關節置換和骨修復至關重要。此外，它們也用於製造需要與口腔組織具有高相容性和強度的重建器械。此外，包括神經內科和心臟病學在內的關鍵領域需要生物材料來製造神經植入物、腦機介面、支架、心律調節器等。例如，2022年2月，賓州州立大學倫德奎斯特生物醫學創新研究所和加州大學洛杉磯分校的研究人員開發了新型生物材料，以促進血管新生並靶向中風後的免疫反應。根據生物材料市場統計數據，另一類應用涵蓋藥物傳遞系統和眼科等其他應用，生物材料分別為植入物和藥物控制釋放提供客製化解決方案。

按地區分類：

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

北美目前佔據全球市場佔有率的主導地位

這份市場研究報告也對所有主要區域市場進行了全面分析，包括北美（美國和加拿大）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告顯示，北美佔據了生物材料市場的最大佔有率。

北美良好的監管環境，尤其是美國食品藥物管理局 (FDA) 在支持新生物材料和醫療器材快速核准和開發方面所發揮的作用，正在推動區域市場的發展。例如，2019 年 11 月，DiFusion Inc. 的 Xiphos-ZF 脊椎椎間裝置獲得了 FDA 批准，該裝置基於另一種生物材料 Zfuze，即鈦和聚醚醚酮的組合。此外，2023 年 10 月，生物材料平台公司之一 Dimension Inx 宣布 FDA 批准了首款 3D 列印再生骨移植產品 CMFlex。此外，進行脊椎手術的門診手術中心 (ASC) 數量的不斷成長是另一個重要的成長誘導因素。例如，根據 Becker's Healthcare 的資料顯示，2023 年 2 月美國有超過 183 個 ASC 進行微創脊椎手術 (MISS)。除此之外，整形手術的日益普及也進一步刺激了區域市場的發展。此外，包括美國國家科學基金會和美國國家標準與技術研究所在內的多個公共和私人組織推出的舉措，為生物材料的使用提供援助，預計將在預測期內推動北美市場的發展。

競爭格局：

市場研究報告對競爭格局進行了全面分析，並提供了所有主要生物材料市場公司的詳細資料。市場中的一些主要參與者包括：

  • 巴斯夫
  • 伯克利先進生物材料
  • 卡彭特技術公司
  • 膠原蛋白基質公司
  • CoorsTek公司
  • 科比昂公司
  • 登士柏西諾德
  • 贏創工業股份公司
  • 強生公司
  • 荷蘭皇家帝斯曼集團
  • 美敦力公司
  • 史賽克公司
  • 威格斯公司
  • 齊默生物醫學公司

本報告回答的關鍵問題

  • 2024 年全球生物材料市場規模是多少
  • 2025-2033年全球生物材料市場的預期成長率是多少
  • 推動全球生物材料市場的關鍵因素有哪些
  • COVID-19 對全球生物材料市場有何影響
  • 全球生物材料市場按類型分類如何？
  • 全球生物材料市場的主要區域有哪些
  • 全球生物材料市場的主要參與者/公司有哪些

本報告回答的關鍵問題

  • 2024年全球生物材料市場規模？ 2025-2033年全球生物材料市場的預期成長率是多少？
  • 推動全球生物材料市場發展的關鍵因素有哪些？
  • COVID-19 對全球生物材料市場有何影響？
  • 全球生物材料市場依類型分為哪些類型？
  • 全球生物材料市場的主要區域有哪些？
  • 全球生物材料市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球生物材料市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場細分：依類型

  • 天然生物材料
  • 金屬生物材料
  • 陶瓷生物材料
  • 聚合物生物材料

第7章：市場區隔：依應用

  • 神經病學
  • 心臟病學
  • 骨科
  • 傷口護理
  • 牙科
  • 整型手術
  • 其他

第8章：市場區隔：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第9章：SWOT分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 10 章：價值鏈分析

第 11 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 12 章：價格分析

第 13 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • BASF SE
    • Berkeley Advanced Biomaterials
    • Carpenter Technology Corporation
    • Collagen Matrix Inc.
    • CoorsTek Inc.
    • Corbion NV
    • Dentsply Sirona
    • Evonik Industries AG
    • Johnson & Johnson
    • Koninklijke DSM NV
    • Medtronic plc
    • Stryker Corporation
    • Victrex plc
    • Zimmer Biomet
Product Code: SR112025A5892

The global biomaterials market size reached USD 126.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 289.7 Billion by 2033, exhibiting a growth rate (CAGR) of 9.7% during 2025-2033. Continuous advancements in the healthcare industry, along with the rising prevalence of cardiovascular diseases, are primarily propelling the market.

Biomaterials Market Analysis:

  • Major Market Drivers: The increasing number of individuals with musculoskeletal conditions represents one of the primary drivers stimulating the market. Additionally, the rising adoption of these materials in dissolvable sutures and dressings, staples, and clips for wound closure is also acting as another significant growth-inducing factor.
  • Key Market Trends: Several advancements in polymer synthesis, protein and peptide engineering, molecular self-assembly, and microfabrication technologies are among the emerging trends bolstering the market.
  • Geographical Trends: North America exhibits a clear dominance across the market, owing to the expanding geriatric population who often need medical interventions. Moreover, the inflating number of research institutions and robust healthcare infrastructures is impelling the growth of the regional market.
  • Competitive Landscape: As per the biomaterials market overview, some of the prominent companies include BASF SE, Berkeley Advanced Biomaterials, Carpenter Technology Corporation, Collagen Matrix Inc., CoorsTek Inc., Corbion N.V., Dentsply Sirona, Evonik Industries AG, Johnson & Johnson, Koninklijke DSM N.V., Medtronic plc, Stryker Corporation, Victrex plc, and Zimmer Biomet, among many others.
  • Challenges and Opportunities: Stringent regulatory frameworks and extensive preclinical testing are hampering the market. However, the introduction of more predictive in-vivo and in-vitro models to assess biocompatibility before clinical use is expected to augment the market over the forecasted period.

Biomaterials Market Trends:

Development of 3D Printing Technologies

The introduction of novel innovations, including 3D printing technologies, is improving the ways in which medical implants and devices are designed and manufactured. Moreover, they enable the production of patient-specific and complex shapes that are difficult or impossible to achieve with traditional methods. Consequently, these technologies find extensive applications in fields, such as dentistry, orthopedics, prosthetics, etc., where anatomical precision is crucial. This, in turn, is one of the lucrative biomaterials market recent opportunities. For example, in February 2024, Nanavati Max Super Specialty Hospital launched a medical 3D printing laboratory in Mumbai to facilitate high-precision surgeries. This pioneering facility is closely integrated with oncology to offer state-of-the-art precision surgeries that are required to be performed accurately and carefully in reconstructive orthopedic, oncologic, and specialized dentistry surgeries. Additionally, the widespread integration of 3D printing technology in biomaterials for creating customized and complex medical devices and implants tailored to individual patients' anatomies is further gaining extensive traction across the globe. For instance, in October 2023, a study was published that assisted the occupational therapists at the Haukeland University Hospital in Bergen to develop personalized hand orthoses by using 3D printing and scanning technologies, which can reduce pain, minimize deterioration, enhance patient compliance, etc. Apart from this, 3D printing allows for the incorporation of gradients of materials with varying mechanical properties, which is also positively influencing the market. For example, in October 2023, Evonik launched implant-grade filaments and carbon-fiber-reinforced PEEK for numerous medical applications. Furthermore, these technologies assist in the treatment of chronic diseases, which is projected to fuel the overall biomaterials market outlook in the coming years. For example, in July 2023, through joint research with the Korea Research Institute of Bioscience and Biotechnology, the Korea Institute of Machinery and Materials, and the institute under the jurisdiction of the Ministry of Science and ICT launched the world's first 3D bioprinting technology that enhances the function of natural killer (NK) immune cells.

Innovations in Tissue Engineering

Tissue engineering plays an important role in biomaterials research. It is gaining immense popularity for developing biological substitutes to maintain, restore, or improve tissue function. For example, in June 2023, OrganaBio announced the introduction of NeoPAC placenta and umbilical cord tissues that are specifically designed to accelerate the progress of regenerative medicine and cell therapy. Moreover, by providing both Research Use Only (RUO) and clinical-grade tissues, OrganaBio encourages researchers to tap into the potential of birth tissues, thereby enabling the development of innovative therapies to address numerous medical conditions. Apart from this, the rising demand for novel scaffolds that are materials engineered to cause desirable cellular interactions to facilitate the formation of new tissues is also elevating the market. For instance, in June 2023, 3DBioFibR, one of the leading innovators in tissue engineering, released two new collagen fiber products, namely CollaFibR 3D and μCollaFibR scaffold. These variants offer significant benefits for tissue culture and tissue engineering applications. Additionally, the elevating investments in R&D activities and research facilities by various organizations to enable the engineering of more structurally and functionally accurate tissues are contributing to the biomaterials market revenue. For example, in January 2023, the National Institute of Biomedical Imaging and Bioengineering (NIBIB) established the Center for Biomedical Engineering Technology Acceleration (BETA Center), a new intramural research program to accelerate the validation, development, and dissemination of cutting-edge technologies. The center focuses on several areas, such as biosensing, engineered and synthetic biology, biomedical imaging, nanomaterials and biomaterials, etc.

Growing Applications in Wound Dressings

The rising adoption of biomaterials in advanced wound dressings, as they help in improving the healing process and outcomes for numerous types of wounds, including acute and chronic injuries, is acting as a significant growth-inducing factor. Besides this, key players are developing sustainable materials for wound care. For example, in March 2024, a team of scientists at the Institute of Advanced Study in Science and Technology (IASST), under the Department of Science and Technology, introduced an eco-friendly wound dressing material made using banana fibers. Moreover, all the materials utilized in creating this innovative dressing material are locally available and natural, making the manufacturing process cost-effective, simple, and non-toxic. Apart from this, the increasing inclination towards bio-material-based wound dressings is elevating the biomaterials market prices. They can be produced from various materials, including foams, hydrogels, films, etc., that are often imbued with bioactive substances like antimicrobial agents to reduce infection and promote tissue regeneration. For instance, in May 2022, Amferia AB, a Swedish medical device startup, was granted a foundational patent by the U.S. Patent and Trademark Office (USPTO) for an antimicrobial material based on an amphiphilic antimicrobial hydrogel. In line with this, in June 2023, according to the findings published in the Journal of Biomaterials Advances, a team of researchers from Queen's University of Belfast designed a 3D printed bandage, also called a scaffold, which presents an innovative method of treatment to heal diabetic foot ulcers (DFUs).

Global Biomaterials Market Segmentation:

Breakup by Type:

  • Natural Biomaterial
  • Metallic Biomaterial
  • Ceramic Biomaterial
  • Polymeric Biomaterial

Currently, metallic biomaterial accounts for the largest market share

The growth in this segmentation is driven due to exceptional strength, optimal durability, and enhanced biocompatibility exhibited by metallic biomaterials. Consequently, they find extensive load-bearing applications, including dental implants, orthopedic implants, cardiovascular devices, etc. For instance, in April 2024, Boston Micro Fabrication (BMF) announced the U.S. Food and Drug Administration (FDA) clearance for its innovative UltraThineer material. Moreover, several metals, such as stainless steel, titanium, cobalt-chromium alloys, etc., are widely used, owing to their superior mechanical properties that ensure longevity and resilience under the stress of bodily movements. For example, in January 2022, according to the journal Colloids and Surfaces A, researchers efficiently modified a TC26 alloy with nanoporous TiO2 to enhance the osseointegration and bioactivity of artificial implants. In addition to this, in June 2023, Technopolis Moscow SEZ announced the production of titanium implants. As a result, the increasing product applications will continue to drive the metallic biomaterials market demand in the coming years.

Breakup by Application:

  • Neurology
  • Cardiology
  • Orthopedics
  • Wound Care
  • Dental
  • Plastic Surgery
  • Others

Durable ceramic, metallic, and polymer-based materials are essential for joint replacements and bone repair. Moreover, they are adopted in the manufacturing of reconstructive devices that require high compatibility and strength with oral tissues. Apart from this, key areas, including neurology and cardiology, require biomaterials for neural implants, brain-machine interfaces, stents, pacemakers, etc. For instance, in February 2022, Researchers at the Lundquist Institute for Biomedical Innovation, Penn State, and the University of California Los Angeles developed novel biomaterials to promote new blood vessels and target post-stroke immune responses. According to the biomaterials market statistics, the other category encompasses additional applications like drug delivery systems and ophthalmology, where biomaterials offer tailored solutions for implants and controlled medication release, respectively.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America currently dominates the global market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest biomaterials market share.

The favorable regulatory environment in North America, particularly the role of the U.S. Food and Drug Administration (FDA), which supports the rapid approval and development of new biomaterials and medical devices, is fueling the regional market. For example, in November 2019, DiFusion Inc. received FDA approval for its Xiphos-ZF spinal interbody device, which is based on a different biomaterial Zfuze, a combination of titanium and poly-ether-ether-ketone. Additionally, in October 2023, Dimension Inx, one of the biomaterials platform companies, announced the FDA approval of CMFlex, the first 3D-printed regenerative bone graft product. Moreover, the growing number of ambulatory surgical centers (ASCs) that perform spinal surgeries is acting as another significant growth-inducing factor. For instance, in February 2023, according to Becker's Healthcare data showcased that more than 183 ASCs in the United States perform minimally invasive spine surgery (MISS). Apart from this, the inflating popularity of cosmetic surgeries is further stimulating the regional market. In addition, the launch of initiatives undertaken by several public and private organizations, including the National Science Foundation and the National Institute of Standards and Technology, which provide assistance pertaining to biomaterials usage, is expected to fuel the market in North America over the forecasted period.

Competitive Landscape:

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major biomaterials market companies have also been provided. Some of the key players in the market include:

  • BASF SE
  • Berkeley Advanced Biomaterials
  • Carpenter Technology Corporation
  • Collagen Matrix Inc.
  • CoorsTek Inc.
  • Corbion N.V.
  • Dentsply Sirona
  • Evonik Industries AG
  • Johnson & Johnson
  • Koninklijke DSM N.V.
  • Medtronic plc
  • Stryker Corporation
  • Victrex plc
  • Zimmer Biomet

Key Questions Answered in This Report

  • 1.What was the size of the global biomaterials market in 2024?
  • 2.What is the expected growth rate of the global biomaterials market during 2025-2033?
  • 3.What are the key factors driving the global biomaterials market?
  • 4.What has been the impact of COVID-19 on the global biomaterials market?
  • 5.What is the breakup of the global biomaterials market based on type?
  • 6.What are the key regions in the global biomaterials market?
  • 7.Who are the key players/companies in the global biomaterials market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Biomaterials Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Natural Biomaterial
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Metallic Biomaterial
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Ceramic Biomaterial
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Polymeric Biomaterial
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Neurology
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cardiology
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Orthopedics
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Wound Care
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Dental
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Plastic Surgery
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Others
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 BASF SE
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Berkeley Advanced Biomaterials
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Carpenter Technology Corporation
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Collagen Matrix Inc.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 CoorsTek Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 Corbion N.V.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Dentsply Sirona
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Evonik Industries AG
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Johnson & Johnson
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Koninklijke DSM N.V.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Medtronic plc
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
      • 13.3.11.4 SWOT Analysis
    • 13.3.12 Stryker Corporation
      • 13.3.12.1 Company Overview
      • 13.3.12.2 Product Portfolio
      • 13.3.12.3 Financials
      • 13.3.12.4 SWOT Analysis
    • 13.3.13 Victrex plc
      • 13.3.13.1 Company Overview
      • 13.3.13.2 Product Portfolio
      • 13.3.13.3 Financials
    • 13.3.14 Zimmer Biomet
      • 13.3.14.1 Company Overview
      • 13.3.14.2 Product Portfolio
      • 13.3.14.3 Financials
      • 13.3.14.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Biomaterials Market: Major Drivers and Challenges
  • Figure 2: Global: Biomaterials Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Biomaterials Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Biomaterials Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Biomaterials Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Biomaterials Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Biomaterials (Natural Biomaterial) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 8: Global: Biomaterials (Natural Biomaterial) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 9: Global: Biomaterials (Metallic Biomaterial) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Biomaterials (Metallic Biomaterial) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Biomaterials (Ceramic Biomaterial) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Biomaterials (Ceramic Biomaterial) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Biomaterials (Polymeric Biomaterial) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Biomaterials (Polymeric Biomaterial) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Biomaterials (Neurology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Biomaterials (Neurology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Biomaterials (Cardiology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Biomaterials (Cardiology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Biomaterials (Orthopedics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Biomaterials (Orthopedics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Biomaterials (Wound Care) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Biomaterials (Wound Care) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Biomaterials (Dental) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Biomaterials (Dental) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Biomaterials (Plastic Surgery) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Biomaterials (Plastic Surgery) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Biomaterials (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Biomaterials (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: North America: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: North America: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: United States: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: United States: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Canada: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Canada: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Asia-Pacific: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Asia-Pacific: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: China: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: China: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Japan: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Japan: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: India: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: India: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: South Korea: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: South Korea: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Australia: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Australia: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Indonesia: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Indonesia: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Others: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Others: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Europe: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Europe: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Germany: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Germany: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: France: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: France: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: United Kingdom: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: United Kingdom: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Italy: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Italy: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Spain: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Spain: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Russia: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Russia: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Others: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Others: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Latin America: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Latin America: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Brazil: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Brazil: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Mexico: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Mexico: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Others: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Others: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Middle East and Africa: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Middle East and Africa: Biomaterials Market: Breakup by Country (in %), 2024
  • Figure 77: Middle East and Africa: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Global: Biomaterials Industry: SWOT Analysis
  • Figure 79: Global: Biomaterials Industry: Value Chain Analysis
  • Figure 80: Global: Biomaterials Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Biomaterials Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Biomaterials Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Biomaterials Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Biomaterials Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 5: Global: Biomaterials Market: Competitive Structure
  • Table 6: Global: Biomaterials Market: Key Players